Dmitry Balyasny’s Precigen PGEN Stock Holding History

Dmitry Balyasny’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$184K	Sell	32,283 -96,691	-75%	-$418K	﹤0.01%	2835
2026 Q1	$499K	Buy	+128,974	New	+$529K	﹤0.01%	2365
2025 Q4	–	Sell	-53,354	Closed	-$176K	–	3457
2025 Q3	$176K	Buy	+53,354	New	+$151K	﹤0.01%	2744
2023 Q1	–	Sell	-18,136	Closed	-$27.6K	–	3031
2022 Q4	$27.6K	Buy	+18,136	New	+$31.2K	﹤0.01%	2441
2022 Q2	–	Sell	-25,652	Closed	-$54K	–	3072
2022 Q1	$54K	Buy	+25,652	New	+$62.5K	﹤0.01%	2217
2019 Q1	–	Sell	-102,159	Closed	-$668K	–	1588
2018 Q4	$668K	Buy	+102,159	New	+$1.14M	﹤0.01%	1022
2018 Q1	–	Sell	-34,177	Closed	-$394K	–	2239
2017 Q4	$394K	Buy	+34,177	New	+$509K	﹤0.01%	1636
2017 Q3	–	Sell	-18,500	Closed	-$446K	–	2049
2017 Q2	$446K	Buy	+18,500	New	+$406K	﹤0.01%	1246

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dmitry Balyasny's PGEN Position: Q2 2026 in Review

Dmitry Balyasny reduced its Precigen (PGEN) stake by 75% in Q2 2026, selling an estimated $418K and leaving 32,283 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2835.

Dmitry Balyasny first reported a position in PGEN in Q2 2017 and has held it in 8 quarters since. The position peaked at $668K in Q4 2018. 209 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Dmitry Balyasny held 32,283 shares of Precigen worth $184K as of Q2 2026.
Dmitry Balyasny sold 96,691 Precigen shares in Q2 2026, an estimated $418K.
Precigen made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2835 holding.
Dmitry Balyasny first reported a position in Precigen in Q2 2017 and has held it in 8 quarters since.
Dmitry Balyasny's Precigen position peaked at $668K in Q4 2018.
209 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.